001     288580
005     20250822105238.0
024 7 _ |a 10.1016/j.meegid.2024.105577
|2 doi
024 7 _ |a pmid:38403035
|2 pmid
024 7 _ |a 1567-1348
|2 ISSN
024 7 _ |a 1567-7257
|2 ISSN
037 _ _ |a DKFZ-2024-00426
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Bundschuh, Christian
|b 0
245 _ _ |a Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 - 07/2023.
260 _ _ |a Amsterdam [u.a.]
|c 2024
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726653320_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Apr;119:105577
520 _ _ |a In January 2021, the monitoring of circulating variants of SARS-CoV-2 was initiated in Germany under the Corona Surveillance Act, which was discontinued after July 2023. This initiative aimed to enhance pandemic containment, as specific amino acid changes, particularly in the spike protein, were associated with increased transmission and reduced vaccine efficacy. Our group conducted whole genome sequencing using the ARTIC protocol (currently V4) on Illumina's NextSeq 500 platform (and, starting in May 2023, on the MiSeq DX platform) for SARS-CoV-2 positive specimen from patients at Heidelberg University Hospital, associated hospitals, and the public health office in the Rhine-Neckar/Heidelberg region. In total, we sequenced 26,795 SARS-CoV-2-positive samples between January 2021 and July 2023. Valid sequences, meeting the requirements for upload to the German electronic sequencing data hub (DESH) operated by the Robert Koch Institute (RKI), were determined for 24,852 samples, and the lineage/clade could be identified for 25,912 samples. The year 2021 witnessed significant dynamics in the circulating variants in the Rhine-Neckar/Heidelberg region, including A.27.RN, followed by the emergence of B.1.1.7 (Alpha), subsequently displaced by B.1.617.2 (Delta), and the initial occurrences of B.1.1.529 (Omicron). By January 2022, B.1.1.529 had superseded B.1.617.2, dominating with over 90%. The years 2022 and 2023 were then characterized by the dominance of B.1.1.529 and its sublineages, particularly BA.5 and BA.2, and more recently, the emergence of recombinant variants like XBB.1.5. Since the global dominance of B.1.617.2, the identified variant distribution in our local study, apart from a time delay in the spread of new variants, can be considered largely representative of the global distribution. om a time delay in the spread of new variants, can be considered largely representative of the global distribution.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a ARTIC protocol
|2 Other
650 _ 7 |a Bioinformatics
|2 Other
650 _ 7 |a Heidelberg/Rhine Neckar region
|2 Other
650 _ 7 |a SARS-CoV-2
|2 Other
650 _ 7 |a Whole genome sequencing
|2 Other
700 1 _ |a Weidner, Niklas
|b 1
700 1 _ |a Klein, Julian
|b 2
700 1 _ |a Rausch, Tobias
|0 P:(DE-He78)1706204a709919588b5bf4fa0deda4df
|b 3
|u dkfz
700 1 _ |a Azevedo, Nayara
|b 4
700 1 _ |a Telzerow, Anja
|b 5
700 1 _ |a Mallm, Jan-Philipp
|0 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
|b 6
|u dkfz
700 1 _ |a Kim, Heeyoung
|b 7
700 1 _ |a Steiger, Simon
|0 P:(DE-He78)2d16262c9228b5654242a4115a7bfc53
|b 8
|u dkfz
700 1 _ |a Seufert, Isabelle
|0 P:(DE-He78)bdcbf8851ab9470be0ffb051cf3d96a1
|b 9
|u dkfz
700 1 _ |a Börner, Kathleen
|b 10
700 1 _ |a Bauer, Katharina
|0 P:(DE-He78)5b10e57ed1df98e2fd31edbdeed985ba
|b 11
|u dkfz
700 1 _ |a Hübschmann, Daniel
|0 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
|b 12
|u dkfz
700 1 _ |a Jost, Katharina Laurence
|b 13
700 1 _ |a Parthé, Sylvia
|b 14
700 1 _ |a Schnitzler, Paul
|b 15
700 1 _ |a Boutros, Michael
|0 P:(DE-He78)3c0da8e3caa2aa50cad85152aa0465ad
|b 16
|u dkfz
700 1 _ |a Rippe, Karsten
|0 P:(DE-He78)94de5f7413279464b6e738d91dfae1eb
|b 17
|u dkfz
700 1 _ |a Müller, Barbara
|b 18
700 1 _ |a Bartenschlager, Ralf
|0 P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387
|b 19
|u dkfz
700 1 _ |a Kräusslich, Hans-Georg
|b 20
700 1 _ |a Benes, Vladimir
|b 21
773 _ _ |a 10.1016/j.meegid.2024.105577
|g p. 105577 -
|0 PERI:(DE-600)2057622-5
|p 105577
|t Infection, genetics and evolution
|v 119
|y 2024
|x 1567-1348
856 4 _ |u https://inrepo02.dkfz.de/record/288580/files/1-s2.0-S1567134824000285-main.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288580/files/1-s2.0-S1567134824000285-main.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:288580
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-He78)1706204a709919588b5bf4fa0deda4df
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)2d16262c9228b5654242a4115a7bfc53
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)bdcbf8851ab9470be0ffb051cf3d96a1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)5b10e57ed1df98e2fd31edbdeed985ba
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)3c0da8e3caa2aa50cad85152aa0465ad
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)94de5f7413279464b6e738d91dfae1eb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-01-06T15:48:35Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-01-06T15:48:35Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-01-06T15:48:35Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INFECT GENET EVOL : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-19
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-19
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-19
920 1 _ |0 I:(DE-He78)W192-20160331
|k W192
|l scOpen Lab
|x 0
920 1 _ |0 I:(DE-He78)B066-20160331
|k B066
|l B066 Chromatin-Netzwerke
|x 1
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 2
920 1 _ |0 I:(DE-He78)B110-20160331
|k B110
|l B110 Signalwege funktionelle Genomik
|x 3
920 1 _ |0 I:(DE-He78)F170-20160331
|k F170
|l Virus-assoziierte Karzinogenese
|x 4
920 1 _ |0 I:(DE-He78)D430-20160331
|k D430
|l Virus-assoziierte Karzinogenese
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)W192-20160331
980 _ _ |a I:(DE-He78)B066-20160331
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)B110-20160331
980 _ _ |a I:(DE-He78)F170-20160331
980 _ _ |a I:(DE-He78)D430-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21